Small Macular Holes Treated With Air

Launched by HELSE STAVANGER HF · Jan 17, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a way to treat small holes in the macula, which is the part of the eye responsible for sharp vision. The study is comparing two methods of helping these holes close: using air versus using a gas bubble inside the eye. Researchers want to find out if using air is just as effective as using gas for this treatment.

To participate in this trial, you need to be at least 18 years old and have a primary macular hole that is smaller than 250 micrometers and has been present for less than 12 months. You should not have had any previous eye surgery on the eye being treated. If you join, you can expect to receive either air or gas treatment and will be monitored throughout the process. This trial is currently recruiting participants of all genders aged 18 and older. If you have any other eye conditions or have previously participated in this study, you may not be eligible.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Primary MH ≤250 μm
• • MH duration ≤12 months
• • No previous vitreoretinal surgery in study eye
• • Ability to sign informed consent
• • Signed informed consent
• • Age ˃18 years
• Exclusion Criteria:
• • Previous vitreoretinal surgery in study eye
• • Secondary MH caused by other conditions than vitreomacular traction
• • Myopic MH, i.e., excessive myopia (more than -6 dioptres)
• • Traumatic MH
• • MH secondary to retinal detachment or other retinal diseases
• • Previously participation in this study